Six-Marker Blood Test Shows Promise for CRC Screening in High-Risk Patients

▪ SCREENING

A prospective study evaluated a multi-target DNA methylation panel (Septin9 region 1, BCAT1, IKZF1, BCAN, VAV3, Septin9 region 2) assessed in plasma samples for colorectal cancer risk stratification, offering a potential non-invasive alternative to colonoscopy. (Clin Chem Lab Med)